NM_004100.5:c.1035G>C

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_004100.5(EYA4):​c.1035G>C​(p.Arg345Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00062 in 1,613,750 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00043 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00064 ( 1 hom. )

Consequence

EYA4
NM_004100.5 missense

Scores

2
10
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:8

Conservation

PhyloP100: 2.11

Publications

8 publications found
Variant links:
Genes affected
EYA4 (HGNC:3522): (EYA transcriptional coactivator and phosphatase 4) This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may act as a transcriptional activator through its protein phosphatase activity, and it may be important for eye development, and for continued function of the mature organ of Corti. Mutations in this gene are associated with postlingual, progressive, autosomal dominant hearing loss at the deafness, autosomal dominant non-syndromic sensorineural 10 locus. The encoded protein is also a putative oncogene that mediates DNA repair, apoptosis, and innate immunity following DNA damage, cellular damage, and viral attack. Defects in this gene are also associated with dilated cardiomyopathy 1J. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
EYA4 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 10
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy 1J
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.23357421).
BP6
Variant 6-133481527-G-C is Benign according to our data. Variant chr6-133481527-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 192118.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000427 (65/152106) while in subpopulation NFE AF = 0.000853 (58/68020). AF 95% confidence interval is 0.000677. There are 0 homozygotes in GnomAd4. There are 24 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 65 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004100.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EYA4
NM_004100.5
MANE Select
c.1035G>Cp.Arg345Ser
missense
Exon 12 of 20NP_004091.3
EYA4
NM_001301013.2
c.1053G>Cp.Arg351Ser
missense
Exon 12 of 20NP_001287942.1
EYA4
NM_172105.4
c.1035G>Cp.Arg345Ser
missense
Exon 12 of 20NP_742103.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EYA4
ENST00000355286.12
TSL:1 MANE Select
c.1035G>Cp.Arg345Ser
missense
Exon 12 of 20ENSP00000347434.7
EYA4
ENST00000531901.5
TSL:2
c.1053G>Cp.Arg351Ser
missense
Exon 12 of 20ENSP00000432770.1
EYA4
ENST00000431403.3
TSL:5
c.966G>Cp.Arg322Ser
missense
Exon 11 of 19ENSP00000404558.3

Frequencies

GnomAD3 genomes
AF:
0.000427
AC:
65
AN:
152106
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000853
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000459
AC:
115
AN:
250806
AF XY:
0.000531
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000955
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000640
AC:
936
AN:
1461644
Hom.:
1
Cov.:
31
AF XY:
0.000666
AC XY:
484
AN XY:
727160
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33468
American (AMR)
AF:
0.0000224
AC:
1
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.0000936
AC:
5
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.000818
AC:
910
AN:
1111818
Other (OTH)
AF:
0.000315
AC:
19
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
51
102
154
205
256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000427
AC:
65
AN:
152106
Hom.:
0
Cov.:
32
AF XY:
0.000323
AC XY:
24
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41422
American (AMR)
AF:
0.00
AC:
0
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000853
AC:
58
AN:
68020
Other (OTH)
AF:
0.000479
AC:
1
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000672
Hom.:
0
Bravo
AF:
0.000382
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.000593
AC:
72
EpiCase
AF:
0.00104
EpiControl
AF:
0.000296

ClinVar

ClinVar submissions as Germline

Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
1
2
not specified (3)
-
1
1
Dilated cardiomyopathy 1J (2)
-
-
1
Autosomal dominant nonsyndromic hearing loss 10 (1)
-
1
-
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.87
BayesDel_addAF
Benign
-0.066
T
BayesDel_noAF
Uncertain
0.13
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.072
T
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.057
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.95
D
M_CAP
Uncertain
0.092
D
MetaRNN
Benign
0.23
T
MetaSVM
Benign
-0.55
T
MutationAssessor
Uncertain
2.0
M
PhyloP100
2.1
PrimateAI
Pathogenic
0.79
T
PROVEAN
Uncertain
-3.2
D
REVEL
Uncertain
0.58
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.015
D
Polyphen
0.84
P
Vest4
0.71
MutPred
0.32
Gain of phosphorylation at R351 (P = 0.0042)
MVP
0.77
MPC
0.37
ClinPred
0.13
T
GERP RS
3.5
Varity_R
0.58
gMVP
0.63
Mutation Taster
=47/53
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140170914; hg19: chr6-133802665; API